A roadmap of strategies to support cardiovascular researchers: from policy to practice

Niamh Chapman1, Emma E Thomas2,3, Joanne T M Tan4,5

  • 1Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

Insights

Cardiovascular research is vital but faces funding, job security, and diversity challenges. This roadmap offers solutions for capacity building, funding, and equity to support researchers and advance cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Science
  • Medical Research Policy

Background:

  • Cardiovascular disease is the leading global cause of mortality.
  • Current challenges in cardiovascular research include funding decline, job insecurity, and lack of senior leadership diversity.
  • Many researchers, especially women, consider leaving the field, necessitating retention strategies.

Purpose of the Study:

  • To present solutions for global cardiovascular researchers facing career progression barriers.
  • To address critical issues impacting the effectiveness and retention of cardiovascular scientists.
  • To outline strategies for improving the research environment in cardiovascular disease.

Main Methods:

  • This study is presented as a "Roadmap article" outlining proposed solutions.
  • Solutions are broadly classified into three key areas: capacity building, research funding, and fostering diversity and equity.
  • The article targets research institutions, governments, and funding bodies to implement policy and practice changes.

Main Results:

  • Identifies key challenges hindering cardiovascular researcher career progression.
  • Proposes actionable solutions across capacity building, funding, and diversity initiatives.
  • Highlights the need for systemic changes to support and retain researchers in the cardiovascular field.

Conclusions:

  • Implementing the proposed solutions can significantly improve the research environment for cardiovascular scientists.
  • Addressing funding, diversity, and capacity building is crucial for advancing cardiovascular disease research.
  • This roadmap provides a framework for stakeholders to foster a more supportive and equitable environment for cardiovascular researchers worldwide.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
48
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
359
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
38
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
47
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.0K